Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US House Commerce Committee bill for FDA reform due this month:

This article was originally published in Clinica

Executive Summary

The US House Commerce Committee is expected to introduce its FDA reform bill this month. In support of Tom Bliley's "comprehensive package" of reforms, House Republicans have requested the legislation be given priority this year, says industry association HIMA. The budgetary problems could jeopardise FDA reform legislation, warns HIMA, since if this controversial issue is not discussed soon it is unlikely to be taken up as the 1996 election approaches. A hearing on Senator Nancy Kassebaum's bill has been set for February 21st-22nd.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT087243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel